N.J. Admin. Code § 13:45A-27.3

Current through Register Vol. 56, No. 24, December 18, 2024

Section 13:45A-27.3 - NJPB required for prescriptions

(a) A written prescription issued by a licensed prescriber shall appear on either the personal NJPB of the licensed prescriber or the NJPB of a licensed healthcare facility obtained from a vendor approved by the Division pursuant to this subchapter.

(b) A licensed prescriber affiliated with a healthcare facility licensed pursuant to P.L. 1971, c. 136 (N.J.S.A. 26:2H-1 et seq.), may use the NJPB of the licensed facility provided that:

1. The prescription is written for a patient treated at that healthcare facility;

2. The name and license number of the licensed prescriber, and the prescriber's National Provider Identifier (NPI) number, if the prescriber has obtained an NPI number, is legibly written, typed, stamped or otherwise affixed to the NJPB;

3. The prescription contains the signature of the licensed prescriber; and

4. If the prescription is for a controlled dangerous substance, the licensed prescriber's Federal Drug Enforcement Administration (DEA) registration number shall be pre-printed, legibly written, typed, stamped, or otherwise affixed to the NJPB.

(c) A separate NJPB shall be utilized for each prescription written for a controlled dangerous substance. The licensed prescriber's Federal DEA registration number shall be pre-printed, legibly written, typed, stamped, or otherwise affixed to the NJPB. No other medication shall appear on the prescription.

(d) If a licensed prescriber utilizes an NJPB pre-printed with multiple drugs, the prescriber shall obliterate, by a cross-off procedure, any drug that is not being prescribed.

(e) A prescription transmitted verbally or transmitted electronically by telephone, facsimile, modem, or other means to a pharmacy by a licensed prescriber shall be exempt from the requirement of utilizing an NJPB if the licensed prescriber provides the pharmacist with his or her license number, DEA number, as appropriate to the particular prescription and NPI number, if the prescriber has obtained an NPI number, at the time of transmission of the prescription, and the pharmacist satisfies the requirements of N.J.A.C. 13:39-7.10, 7.11, or 9.27.

1. A prescriber licensed by the State Board of Medical Examiners who transmits a facsimile or electronic prescription shall also comply with all requirements set forth in N.J.A.C. 13:35-7.4 and 7.4A.

(f) A licensed prescriber writing a prescription for a Schedule II narcotic substance to be compounded for direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion, or a prescription for a Schedule II narcotic substance for a hospice patient, or a prescription for any Schedule II substance for a long-term care facility resident, shall be exempt from the requirement of utilizing an NJPB if the prescription is transmitted or prepared in compliance with DEA regulations as set forth in 21 CFR 1306.11(d), (e), (f), and (g), consistent with the requirements set forth at N.J.A.C. 13:39-7.10, 7.11, or 9.27.

1. A prescriber licensed by the State Board of Medical Examiners writing a prescription for a Schedule II narcotic substance to be compounded for direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous or intraspinal infusion, or a prescription for a Schedule II narcotic substance for a hospice patient, or a prescription for any Schedule II substance for a long-term care facility resident, shall also comply with all requirements set forth in N.J.A.C. 13:35-7.4 and 7.4A.

N.J. Admin. Code § 13:45A-27.3

Amended by R.2010 d.043, effective 2/16/2010.
See: 41 N.J.R. 2624(a), 42 N.J.R. 592(a).
In the introductory paragraph of (b), substituted "c. 136" for "c.136"; in (b)2, inserted ", and the prescriber's National Provider Identifier (NPI) number, if the prescriber has obtained an NPI number," and deleted a comma following "stamped"; and in the introductory paragraph of (e), deleted a comma following "modem", substituted a comma for "and" preceding "DEA" and inserted "and NPI number, if the prescriber has obtained an NPI number".
Amended by R.2014 d.033, effective 2/18/2014.
See: 44 N.J.R. 2453(a), 46 N.J.R. 391(a).
In (b)4, substituted "shall be pre-printed," for "is"; in (c), inserted the second sentence; in the introductory paragraph of (e) and of (f), updated the N.J.A.C. references; in the introductory paragraph of (e), inserted a comma following "modem"; and in the introductory paragraph of (f), inserted a comma following "subcutaneous" and following "(f)", and substituted "CFR" for "C.F.R.".